Summary of Key Points
At Apple's autumn launch event, everyone's attention was drawn to the new iPhone and the new Apple Watch, with hardly anyone noticing the significant updates to the Apple Health app. However, this seemingly inconspicuous app is actually the most ambitious new product of the event. It has made the core services of measuring "biological age" and interpreting lab test results, which used to cost hundreds or even thousands of dollars in the longevity industry, completely free. It has also established a direct link for ordering third-party blood tests, effectively lowering the barriers to this once highly complex and costly industry. This move could potentially repeat the success Apple Watch had with mid-range Swiss watches, completely reshaping the global health and longevity business.
---
Detailed Analysis
1. The Health App That Everyone Overlooked Hides Apple's Most Urgent Profit-Making Strategy
Many people are puzzled: Why would Apple focus on upgrading a health app rather than promoting new hardware? The reason is that Apple's hardware business has hit a growth bottleneck. In the past, people replaced their phones and watches every 1-2 years, but now the cycle has extended to 3-4 years, slowing down the growth of hardware revenue.
Apple already generates over $100 billion in revenue annually from services such as iCloud and subscription memberships, accounting for 26% of its total revenue. Health services are particularly sticky for users: once you start tracking your sleep, heart rate, and exercise data with an Apple Watch for three years, you're reluctant to switch to an Android device. Even if the health services incur a fee, the psychological cost of canceling the subscription is high.
This time, Apple didn't follow the traditional approach of charging for a combined health subscription. Instead, it made most of the core functions free and only earns transaction commissions by linking users to third-party testing services within the app. This turns the health app into a "Meituan" for health services—users place orders for blood tests directly through the app, and Apple connects them with existing testing laboratories without having to invest heavily in infrastructure or setting up own testing sites, thus avoiding the complex regulatory challenges in the healthcare industry.
2. Making "Esoteric Biological Age" Free, Apple Overthrows the Mid-Range Longevity Industry
The traditional longevity industry relied on calculating users' "biological age" and charging a fee for blood tests, with the core service being an interpretation of lab results that suggested users were older than their actual age. However, the algorithms used by these companies were often opaque, and there were no uniform standards. Apple has now made this core service free, using data from the watch (such as maximum oxygen capacity, resting heart rate, and sleep patterns) along with user-submitted lab test results to automatically calculate a biological age and provide daily recommendations. A free and convenient service, even if less accurate than paid options, is unlikely to attract users to spend hundreds of dollars on longevity clinics. This is similar to how Apple Watch disrupted the mid-range Swiss watch market, taking over a market previously dominated by high-priced products.
3. The Testing Labs That Seem to Be Suffering Are Actually the Biggest Winners
Some think Apple is unfair by pricing a blood test package at $119, which is nearly three times cheaper than Quest's own website price of $399. However, Quest is actually the biggest winner in this deal. With Apple's massive user base, it has suddenly gained a huge number of new customers. Although users may only remember purchasing the test through Apple, Quest still benefits significantly from the increased orders. Apple doesn't compete with high-end services like MRI scans or genetic sequencing, so its business is not affected.
4. Apple Shows Domestic Manufacturers a Path Forward
Some argue that since Apple's services are only available in the US and partnered with US-based labs, they have no relevance to China. This is a misconception. Apple has paved a new path for the domestic health industry: by using its smartphone and watch users as a platform to connect consumers with testing services, it eliminates the need for customers to visit hospitals or wait in lines. This model has been proven successful, and with China's growing smartphone market (led by companies like Huawei, Xiaomi, and OPPO), domestic manufacturers can leverage this opportunity to develop their own health and longevity services. While Apple's health app is still in its early stages in China, domestic companies can quickly catch up by collaborating with local labs and providing comprehensive health management services.
In summary, Apple's updates to the Apple Health app have not only transformed the health and longevity industry but also shown domestic manufacturers a clear path to success.